Invention Grant
US08110195B2 Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody
有权
抗体组合物由于糖基化而显示细胞毒性并含有神经节苷脂GM2结合抗体
- Patent Title: Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody
- Patent Title (中): 抗体组合物由于糖基化而显示细胞毒性并含有神经节苷脂GM2结合抗体
-
Application No.: US12818735Application Date: 2010-06-18
-
Publication No.: US08110195B2Publication Date: 2012-02-07
- Inventor: Yutaka Kanda , Mitsuo Satoh , Kazuyasu Nakamura , Kazuhisa Uchida , Toyohide Shinkawa , Naoko Yamane , Motoo Yamasaki , Nobuo Hanai , Emi Hosaka , Kazuya Yamano
- Applicant: Yutaka Kanda , Mitsuo Satoh , Kazuyasu Nakamura , Kazuhisa Uchida , Toyohide Shinkawa , Naoko Yamane , Motoo Yamasaki , Nobuo Hanai , Emi Hosaka , Kazuya Yamano
- Applicant Address: JP Tokyo
- Assignee: Kyowa Hakko Kirin Co., Ltd.
- Current Assignee: Kyowa Hakko Kirin Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2000-308526 20001006; WOPCT/JP01/08804 20011005
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/00 ; C12P21/08
Abstract:
The present invention relates to a cell for the production of an antibody molecule such as an antibody binding to ganglioside GM2, a fragment of the antibody and a fusion protein having the Fc region of the antibody or the like, a method for producing an antibody composition using the cell, the antibody composition and use thereof.
Public/Granted literature
- US20110059115A1 ANTIBODY COMPOSITION EXHIBITING CELLULAR CYTOTOXICTY DUE TO GLYCOSYLATION Public/Granted day:2011-03-10
Information query
